17.000
+3,66%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +200.2% | -172.7% | 2 / 3 | +192.1% | +13.13 pp | +1.38 pp | +11.5% | 0.02 | 10.23 | 31,5 | +192,1% | 15,5 | +200,5% | 10.23 | 7.49 | +36,5% |
| Pts | 12 | 0 | 8 | 12 | 12 | 8 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 17.000 (close price on 2026-10-19)EPS (TTM): 1.662
Financial charts
1.Revenue & growth
VND bn31,5Q2/26
1.Revenue & growth
VND bn31,5Q2/26
2.Profit & growth
VND bn14,1Q2/26
3.Profit mix (Penman)
VND bn30,9Q2/26
4.Margins & cost structure
%5.9%Q2/26
5.Returns & cash cycle
% · days-8.1%Q2/26
6.Earnings quality & cash
VND bn12,6Q2/26
7.Asset structure
VND bn329Q2/26
8.Funding & debt health
VND bn · times329Q2/26
9.Revenue backlog
VND bn1,21Q2/26
10.Valuation
times · %10,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %728Q2/26
Adjusted EPS growth, latest quarter
174%
Average adjusted EPS growth, 3 quarters
-182%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26